Biogen (BIIB) PT Lowered to $206 at Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald analyst Eric Schmidt lowered the price target on Biogen (NASDAQ: BIIB) to $206.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
